Imaging radiotherapy-induced apoptosis

Radiation Research

Volumn 177, Issue 4, 2012, Pages 467-482

  Haimovitz Friedman, Adriana ^a   Yang, Tzu I Jonathan ^b   Thin, Tin Htwe ^a   Verheij, Marcel ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; HUMAN; IMAGING SYSTEM; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOTHERAPY; TREATMENT RESPONSE;

ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASE 3; CHEMORADIOTHERAPY; CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; MICE; MICROBUBBLES; MOLECULAR IMAGING; NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECEPTORS, DEATH DOMAIN; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84859778298     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2576.1     Document Type: Article

References (146)

1. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001; 2(8): 589-98. (Pubitemid 33674010)
2. Dubray B, Breton C, Delic J, Klijanienko J, Maciorowski Z, Vielh P, et al. In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in nonHodgkin's lymphomas. Radiother Oncol. 1998; 46(2): 185-91. (Pubitemid 28109177)
3. Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, et al. Chemosensitization of malignant melanoma by BCL2 antisense therapy. Lancet. 2000; 356(9243): 1728-33.
4. Symmans WF, Volm MD, Shapiro RL, Perkins AB, Kim AY, Demaria S, et al. Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment. Clin Cancer Res. 2000; 6(12): 4610-7. (Pubitemid 32110395)
5. Meyn RE, Stephens LC, Hunter NR, Milas L. Apoptosis in murine tumors treated with chemotherapy agents. Anticancer Drugs. 1995; 6(3): 443-50.
6. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997; 349(9055): 849. (Pubitemid 27129217)
7. Orrenius S. Apoptosis: molecular mechanisms and implications for human disease. J Intern Med. 1995; 237: 529-36.
8. Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony. Biochem Biophys Res Commun. 1999; 266(3): 699-717. (Pubitemid 30042495)
9. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002; 1(2): 111-21. (Pubitemid 41646518)
10. Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res. 2001; 488(3): 211-31. (Pubitemid 32521033)
11. Wu J. Apoptosis and angiogenesis: two promising tumor markers in breast cancer. Anticancer Res. 1996; 16: 2233-9. (Pubitemid 26265571)
12. Olson M, Kornbluth S. Mitochondria in apoptosis and human disease. Curr Mol Med. 2001; 1: 91-122. (Pubitemid 33772972)
13. Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 2002; 9: 367-93. (Pubitemid 34822817)
14. Meyn RE, Milas L, Ang KK. The role of apoptosis in radiation oncology. Int J Radiat Biol. 2009; 85(2): 107-15.
15. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239-57.
16. Bredesen DE. Genetic control of neural cell apoptosis. Perspect Dev Neurobiol. 1996; 3(2): 101-9. (Pubitemid 126812786)
17. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Rob C, van Schie AA, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995; 182: 1545-56.
18. Ashkenazi A. Targeting death and decoy receptors of the tumournecrosis factor superfamily. Nat Rev Cancer. 2002; 2(6): 420-30. (Pubitemid 37328939)
19. Sartorius U, Schmitz I, Krammer PH. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem. 2001; 2(1): 20-9.
20. Salvesen GS, Renatus M. Apoptosome: the seven-spoked death machine. Dev Cell. 2002b; 2(3): 256-7. (Pubitemid 34266110)
21. Lee H, Rotolo JA, Mesicek J, Penate-Medina T, Rimner A, Liao WC, et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS One. 2011; 6(6): e19783.
22. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death: Mechanistic aspects and methodological issues. Eur J Biochem. 1999; 264(3): 687-701. (Pubitemid 29437197)
23. Loeffler M, Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res. 2000; 256(1): 19-26. (Pubitemid 30211162)
24. Green DR, Kroemer G. The Pathophysiology of Mitochondrial Cell Death. Science. 2004; 305(5684): 626-9. (Pubitemid 39006738)
25. Balasubramanian K, Mirnikjoo B, Schroit AJ. Regulated externalization of phosphatidylserine at the cell surface: implication for apoptosis. J Biol Chem. 2007; 282 (18357-18364). (Pubitemid 47100238)
26. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988; 335: 440-2.
27. Korsmeyer SJ, McDonnell TJ, Nunez G, Hockenbery D, Young R. Bcl-2: B cell life, death and neoplasia. Curr Top Microbiol Immunol. 1990; 166: 203-7.
28. Zornig M, Busch G, Beneke R, Gulbins E, Lang F, Ma A, et al. Survival and death of prelymphomatous B-cells from N-myc/blc-2 double transgenic mice correlates with the regulation of intracellular Ca2 + fluxes. Oncogene. 1995; 11(10): 2165-74.
29. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001; 15: 2922-33. (Pubitemid 33078942)
30. Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem. 1997; 272: 20317-20. (Pubitemid 27355576)
31. Tepper AD, deVries E, van Blitterswijk WJ, Borst J. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damage-induced apoptosis. J Clin Invest. 1999; 103: 971-8. (Pubitemid 29169604)
32. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 1991; 67(5): 879-88. (Pubitemid 121001502)
33. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 [see comments]. Cell. 1994; 79(2): 329-39.
34. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9(6): 1799-805. (Pubitemid 24163411)
35. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995; 80(2): 293-9.
36. Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res. 2002; 62: 7316-27. (Pubitemid 36025255)
37. Mihara M, Erster S, Zaika A, Petrenko O, Chittendeh T, Pancoska P, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 2003; 11(3): 577-90. (Pubitemid 36385115)
38. Friesen C, Herr I, Krammer PH, Debatin KM. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med. 1996; 2(5): 574-7. (Pubitemid 26150685)
39. Mü ller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest. 1997; 99(3): 403-13. (Pubitemid 27414797)
40. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene. 2001; 20(14): 2190-6. (Pubitemid 32424014)
41. Li X, Link JM, Stekhova S, Yagle KJ, Smith CD, Krohn KA, et al. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug Chem. 2008; 19(8): 1684-8.
42. Laakko T, King L, Fraker P. Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells. J Immunol Methods. 2002; 261(1-2): 129-39. (Pubitemid 34175222)
43. Hanshaw RG, Lakshmi C, Lambert TN, Johnson JR, Smith BD. Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. ChemBioChem. 2005; 6(12): 2214-20.
44. Bose S, Tuunainen I, Parry M, Medina OP, Mancini G, Kinnunen PK. Binding of cationic liposomes to apoptotic cells. Analyt Biochem. 2004; 331(2): 385-94. (Pubitemid 38953091)
45. Quinti L, Weissleder R, Tung C-H. A fluorescent nanosensor for apoptotic cells. Nano Lett. 2006; 6(3): 488-90.
46. Laumonier C, Segers J, Laurent S, Michel A, Coppee F, Belayew A, et al. A new peptidic vector for molecular imaging of apoptosis, identified by phage display technnology. J Biomol Screen. 2006; 11(5): 537-45. (Pubitemid 44223005)
47. Thapa N, Kim SH, So I-S, Lee B-H, Kwon I-C, Choi K, et al. Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis. J Cell Mol. 2008; 12(5A): 1649-60.
48. Sherr CJ. The ins and outs of RB: coupling gene expression to the cell cycle block. Trends Cell Biol. 1994; 4: 15-8. (Pubitemid 24038742)
49. Jung HI, Kettunen MI, Davlevtov B, Brindle KM. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem. 2004; 15(5): 983-7. (Pubitemid 39297818)
50. Smith C, Gibson DF, Tait JF. Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine. BMC Biochem. 2009 Feb 17; 10: 5.
51. Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C, Dierckx RA, Slegers G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging. 2004; 31(6): 887-919. (Pubitemid 38765126)
52. Stratton JR, Dewhurst TA, Kasina S, Reno JM, Cerqueira MD, Baskin DG, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation. 1995; 92: 3113-21.
53. Tait JF. Imaging of apoptosis. J Nucl Med. 2008; 49(10): 1573-6.
54. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med. 1999; 40(1): 184-91. (Pubitemid 29044190)
55. Blankenberg FG. Monitoring of Treatment-Induced Apoptosis in Oncology with PET and SPECT. Curr Pharm Des. 2008; 14: 2974-82.
56. Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, et al. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Eur J Nucl Med. 2001; 28(9): 1373-8.
57. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, et al. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med. 2003; 44(6): 947-52. (Pubitemid 39663407)
58. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000; 356(9225): 209-12. (Pubitemid 30446976)
59. Penn DL, Kim C, Zhang K, Mukherjee A, Devakumar D, Jungkind D, et al. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V. Nucl Med Biol. 2010; 37(1): 29-34.
60. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death.Proc Natl Acad Sci USA. 1998; 95(11): 6349-54. (Pubitemid 28249015)
61. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol. 1993; 64(5): 583-91. (Pubitemid 23350460)
62. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res. 1991; 127(3): 308-16.
63. Guo MF, Zhao Y, Tian R, Li L, Guo L, Xu F, et al. In vivo 99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation. J Exp Clin Cancer Res. 2009; 28: 136.
64. Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, et al. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm. 2001; 16(1): 73-83. (Pubitemid 32231719)
65. Haas RL, de Jong D, Valdés Olmos RA, Hoefnagel CA, van den Heuvel I, Zerp SF, et al. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys. 2004; 59(3): 782-7. (Pubitemid 38748743)
66. Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol. 2004; 72(3): 333-9. (Pubitemid 39265388)
67. Kartachova M, van Zandwijk N, Burgers S, van Tinteren H, Verheij M, Valdés Olmos RA. Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol. 2007; 25(18): 2534-9. (Pubitemid 47041226)
68. Kartachova MS, Valdes Olmos RA, Haas RL, Hoebers FJ, van Herk M, Verheij M. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nucl Med Commun. 2008; 29(1): 39-44. (Pubitemid 351339339)
69. Hoebers FJ, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H, van Herk M, et al. 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2008; 35(3): 509-18.
70. van de Wiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, et al. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol. 2003; 21(18): 3483-7. (Pubitemid 46594081)
71. Verheij M, van Blitterswijk WJ, Bartelink H. Radiation-induced apoptosis-the ceramide-SAPK signaling pathway and clinical aspects. Acta Oncol. 1998; 37(6): 575-81. (Pubitemid 28557218)
72. Loose D, Vermeersch H, De Vos F, Deron P, Slegers G, Van de Wiele C. Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck. Eur J Nucl Med Mol Imaging. 2008; 35(1): 47-52. (Pubitemid 350234151)
73. Vermes I, Haanen C, Stefferns-Nakken H, Reutelingsperger CPM. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184(1): 39-51.
74. Vermes I, Haanen C, Reutelingsperger CPM. Flow cytometry of apoptotic cell death. J Immunol Methods. 2000; 243(1-2): 167-90.
75. Derby E, Reddy V, Kopp W, Nelson E, Baseler M, Sayers T, et al. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol Lett. 2002; 78(1): 35-9.
76. Malyguine A, Derby E, Brooks A, Reddy V, Baseler M, Sayers T. Study of diverse mechanisms of cell-mediated cytotoxicity in gene-targeted mice using flow cytometric cytotoxicity assay. Immunol Lett. 2002; 83(1): 55-9. (Pubitemid 34607539)
77. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A. Near-Infrared Fluorescent Imaging of Tumour Apoptosis. Cancer Res. 2003; 63(8): 1936-42. (Pubitemid 36460861)
78. Ntziachristos V, Schellenberger E, Ripoll J, Yessayan D, Graves E, Bogdanov A, et al. Visualization of antitumour treatment by means of fluorescence molecular tomography with an annexin VCy5.5 conjugate. Proc Natl Acad Sci USA. 2004; 101(33): 12294-99. (Pubitemid 39145437)
79. Zhao M, Beauregard DA, Loizou L, Davlevtov B, Brindle K. Non-Invasive Detection of Apoptosis Using Magnetic Resonance Imaging and a Targeted Contrast Agent. Nat Med. 2001; 7(11): 1241-4. (Pubitemid 33063780)
80. Huber MM, Staubli AB, Kutstedjo K, Gray MH, Shih J, Fraser SE, et al. Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem. 1998; 9(2): 242-9. (Pubitemid 28147142)
81. Modo M, Cash D, Mellodew K, Williams SC, Fraser SE, Meade TJ, et al. Tracking transplanted stem cell migration using bifunctional contrast agent-enhanced magnetic resonance imaging. Neuroimage. 2002; 17(2): 803-11. (Pubitemid 35317014)
82. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, et al. A liposomal system for contrast-enhanced magentic resonance imaging of molecular targets. Bioconjug Chem. 2004; 15(4): 799-806. (Pubitemid 38981954)
83. Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, et al. Molecular imaging and fluorescence microscopy for identifcation of activated tumour endothelium using a bimodal lipidic nanoparticle. FASEB J. 2005; 19(14): 2008-10. (Pubitemid 41759747)
84. Schellenberger E, Sosnovik D, Weissleder R, Josephson L. Magneto/optical annexin v, a multimodal protein. Bioconjug Chem. 2004; 15(5): 1062-67. (Pubitemid 39297828)
85. Sosnovik DE, Schellenberger E, Nahrendorf M, Novikov MS, Matsui T, Dai G, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med. 2005; 54(3): 718-24. (Pubitemid 41233769)
86. Van Tilborg GAF, Mulder WJM, Chin PTK, Storm P, Reutelingsperger CPM, Nicolay K, et al. Annexin A5-Conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem. 2006; 17(4): 865-8. (Pubitemid 44162601)
87. Van Tilborg GAF, Mulder WJ, Deckers N, Storm G, Reutelingsperger CP, Strijkers GJ, et al. Annexin A5-Functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem. 2006; 17(3): 741-49. (Pubitemid 43794385)
88. Blankenberg FG. In vivo detection of apoptosis. J Nucl Med. 2008; 49 Suppl 2: 81S-95S. (Pubitemid 351948038)
89. Kartachova MS, Valdés Olmos RA, Haas RL, Hoebers FJ, van Herk M, Verheij M. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nucl Med Commun. 2001; 29(1): 39-44.
90. Cohen A, Shirvan A, Levin G, Grimberg H, Reshef A, Ziv I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 2009; 19(5): 625-37.
91. Cohen A, Ziv I, Aloya T, Levin G, Kidron D, Grimberg H, et al. Monitoring of chemotherapy-induced cell death in melanoma tumors by N,N0-Didansyl-L- cystine. Technol Cancer Res Treat. 2007; 6(3): 221-34.
92. Aloya R, Shirvan A, Grimberg H, Reshef A, Levin G, Kidron D, et al. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis. 2006; 11(12): 2089-101. (Pubitemid 44885386)
93. Grimberg H, Levin G, Shirvan A, Cohen A, Yogev-Falach M, Reshef A, et al. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis. 2009; 14(3): 257-67.
94. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med. 1990; 31(10): 1646-53. (Pubitemid 20347047)
95. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989; 30(3): 301-11. (Pubitemid 19077319)
96. Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO. Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med. 1998 Jan; 39(1): 91-4.
97. Ceriani L, Giovanella L, Bandera M, Beghe B, Ortelli M, Roncari G. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy. Nucl Med Commun. 1997 Nov; 18(11): 1087-97. (Pubitemid 27523991)
98. Kao CH, ChangLai SP, Chieng PU, Yen TC. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response-a preliminary report. Cancer. 1998 Jul 1; 83(1): 64-8.
99. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Lee JK. Quickly predicting chemotherapy response to paclitaxel-based therapy in nonsmall cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography. Clin Cancer Res. 2000 Mar; 6(3): 820-4.
100. Nishiyama Y, Yamamoto Y, Satoh K, Ohkawa M, Kameyama K, Hayashi E, et al. Comparative study of Tc-99m MIBI and TI-201 SPECT in predicting chemotherapeutic response in nonsmall-cell lung cancer. Clin Nucl Med. 2000 May; 25(5): 364-9. (Pubitemid 30226869)
101. Yamamoto Y, Nishiyama Y, Satoh K, Ohkawa M, Kameyama K, Hayashi E, et al. Comparative evaluation of Tc-99m MIBI and Tl-201 chloride SPECT in nonsmall-cell lung cancer mediastinal lymph node metastases. Clin Nucl Med. 2000 Jan; 25(1): 29-32. (Pubitemid 30029916)
102. Yang TJ, Aukema TS, van Tinteren H, Burgers S, Valdes Olmos R, Verheij M. Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced nonsmall cell lung cancer. Mol Imaging Biol. 2009 Apr; 12(2): 174-80.
103. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med. 1996 Aug; 23(8): 980-6. (Pubitemid 26278801)
104. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med. 1995 May; 22(5): 434-42.
105. Burak Z, Moretti JL, Ersoy O, Sanli U, Kantar M, Tamgac F, et al. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression. J Nucl Med. 2003 Sep; 44(9): 1394-401. (Pubitemid 39663350)
106. Wang XS, Zhang YJ, Liu XL, Zhou ZR, Hu CS, Eisbruch A. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma. Cancer. 2010 Dec 14 [Epub ahead of print].
107. Bellamy WT. P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996; 36: 161-83. (Pubitemid 26169898)
108. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993; 62: 385-427. (Pubitemid 23237876)
109. Muzzammil T, Moore MJ, Hedley D, Ballinger JR. Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of Pglycoprotein function. Br J Cancer. 2001 Feb 2; 84(3): 367-73. (Pubitemid 32154430)
110. Germann UA. P-glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer. 1996 Jun; 32A(6): 927-44.
111. Muzzammil T, Ballinger JR, Moore MJ. 99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer. Nucl Med Commun. 1999 Feb; 20(2): 115-22. (Pubitemid 29166524)
112. Del Vecchio S, Ciarmiello A, Salvatore M. Clinical imaging of multidrug resistance in cancer. Q J Nucl Med. 1999 Jun; 43(2): 125-31. (Pubitemid 29318047)
113. Kao A, Shiun SC, Hsu NY, Sun SS, Lee CC, Lin CC. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and pglycoprotein or multidrug resistance related protein expression. Ann Oncol. 2001 Nov; 12(11): 1561-6. (Pubitemid 34065885)
114. Del Vecchio S, Salvatore M. 99mTc-MIBI in the evaluation of breast cancer biology. Eur J Nucl Med Mol Imaging. 2004 Jun; 31 Suppl 1: S88-96. (Pubitemid 38833037)
115. Del Vecchio S, Zannetti A, Aloj L, Caraco C, Ciarmiello A, Salvatore M. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. Eur J Nucl Med Mol Imaging. 2003 Jun; 30(6): 879-87. (Pubitemid 36734208)
116. Zhu X, Wu H, Xia J, Zhao M, Xianyu Z. The relationship between (99m)Tc-MIBI uptakes and tumor cell death/proliferation state under irradiation. Cancer Lett. 2002 Aug 28; 182(2): 217-22. (Pubitemid 34621186)
117. Vergote J, Di Benedetto M, Moretti JL, Azaloux H, Kouyoumdjian JC, Kraemer M, et al. Could 99mTc-MIBI be used to visualize the apoptotic MCF7 human breast cancer cells? Cell Mol Biol. 2001; 47(3): 467-71.
118. Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, et al. Tumor clearance of technetium 99msestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol. 1998; 16(5): 1677-83. (Pubitemid 28234709)
119. Chen DL, Zhou D, Chu W, Herrbrich PE, Jones LA, Rothfuss JM, et al. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Nucl Med Biol. 2009; 36(6): 651-78.
120. Nguyen QD, Smith G, Glaser M, Perumal M, Arstad E, Aboagye EO. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific[18F]-labeled isatin sulfonamide. Proc Natl Acad Sci USA. 2009; 106: 16375-80.
121. Podichetty AK, Wagner S, Schroer S, Faust A, Schäfers M, Schober O, et al. Fluorinated isatin derivatives. Part 2. New Nsubstituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis. J Med Chem. 2009; 52(11): 3484-95.
122. Zhou D, Chu W, Chen DL, Wang Q, Reichert DE, Rothfuss J, et al. [18F]-and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Org Biomol Chem. 2009; 7(7): 1337-48.
123. Zhou D, Chu W, Rothfuss J, Zeng C, Xu J, Jones L, et al. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg Med Chem Lett. 2006; 16(19): 5041-6. (Pubitemid 44247712)
124. Kopka K, Faust A, Keul P, Wagner S, Breyholz HJ, Hö ltke C, et al. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis. J Med Chem. 2006; 49(23): 6704-15. (Pubitemid 44749738)
125. Lee D, Long SA, Murray JH, Adams JL, Nuttall ME, Nadeau DP, et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem. 2001; 44(12): 2015-26. (Pubitemid 32884524)
126. Coppola JM, Ross BD, Rehemtulla A. Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res. 2008; 14: 2492-501. (Pubitemid 351551085)
127. Faust A, Wagner S, Law MP, Hermann S, Schnöckel U, Keul P, et al. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)- benzyl)-5-[1-(2-methoxymethylpyrrolidinyl) sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging. 2007; 51(1): 67-73. (Pubitemid 46824663)
128. Rosado JA, Lopez JJ, Gomez-Arteta E, Redondo PC, Salido GM, Pariente JA. Early caspase-3 activation independent of apoptosis is required for cellular function. J Cell Physiol. 2006; 209(1): 142-52. (Pubitemid 44318675)
129. Spires-Jones TL, de Calignon A, Matsui T, Zehr C, Pitstick R, Wu HY, et al. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J Neurosci. 2008; 28(4): 862-7. (Pubitemid 351158993)
130. Laxman B., Hall D. E., Bhojani M. S., Hamstra D. a. et al. Non-invasive real-time imaging of apoptosis. P Natl Acad Sci USA. 2002; 99, 16551-5.
131. Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D. Single-cell imaging of retinal ganglion cell apoptosis with a cellpenetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci USA 2009; 106(23): 9391-6.
132. De Keyzer F, Vandecaveye V, Thoeny H, Chen F, Ni Y, Marchal G, et al. Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model. Eur Radiol. 2009; 19: 2663-71.
133. Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson LA. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol. 2009; 48(7): 1034-43.
134. Czarnota GJ, Kolios MC, Abraham J, Portnoy M, Ottensmeyer FP, Hunt JW, et al. Ultrasound imaging of apoptosis: highresolution noninvasive monitoring of programmed cell death in vitro, in situ and in vivo. Br J Cancer. 1999; 81(3): 520-7. (Pubitemid 29458808)
135. Chamnanvanakij S, Margraf LR, Burns D, Perlman JM. Apoptosis and white matter injury in preterm infants. Pediatr Dev Pathol. 2002; 5: 184-9. (Pubitemid 34475452)
136. Tunis AS, Czarnota GJ, Giles A, Sherar MD, Hunt JW, Kolios MC. Monitoring structural changes in cells with high frequency ultrasound signal statistics. Ultrasound Med Biol. 2005; 31: 1041-49. (Pubitemid 41115846)
137. Yucel C, Ozdemir H, Gurel S, Ozer S, Arac M. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver-specific late phase of contrast enhancement with Levovist. J Clin Ultrasound. 2002; 30: 203-12. (Pubitemid 34465101)
138. Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJK, Cosgrove DO. Advances in ultrasound. Clin Radiol. 2002; 57: 157-77.
139. Hohnmann J, Albrecht T, Hoffmann CW, Wolf KJ. Ultrasonographic detection of foval liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol. 2003; 46: 147-59. (Pubitemid 36457936)
140. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996; 94(12): 3334-40. (Pubitemid 26427506)
141. Lindner JR. Detection of inflamed plaques with contrast ultrasound. Am J Cardiol. 2002; 90: 32L-5L. (Pubitemid 35379903)
142. Villanueva FS, Wagner WR, Vannan MA, Narula J. Targeted ultrasound imaging using microbubbles. Cardiol Clin. 2004; 22: 283-98. (Pubitemid 38680772)
143. Thin TH, Garcia-Barros M, Kaag M, Manova K, Powell S, Haimovitz-Friedman A, et al., eds. The mechanism of microvascular engagement in tumor response to high single-dose radiotherapy. AACR 100th Annual Meeting; 2009; Denver, Colorado.
144. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622): 1155-9. (Pubitemid 36583102)
145. Endlich B, Radford IR, Forrester HB, Dewey WC. Computerized video time-lapse microscopy studies of ionizing radiationinduced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiation Research. 2000; 153: 36-48. (Pubitemid 30117082)
146. Verheij M. Clinical biomarkers and imaging for radiotherapyinduced cell death. Cancer Metastasis Rev. 2008; 27(3): 471-80.